المستخلص: |
This study compares the anti tumour effects of the novel NQO1 activated drug RH1 (2, 5-diaziridinyl-3 -hydoxymethyl-6-methyl-1, 4- benzoquinone) with a novel lipophilic ester derivative Es5 on the isogenic cell lines MDA 468 and MDA 468 NQO1 which differs only in expression of wtNQO1. A 39- fold enhancement of growth inhibitory activity was seen in NQO1 expressing cells compared the NQO1 null cells for the Es5 compared to the 25- fold increase seen for the parent drug, RH1. The kinetics of cell cycle arrest, apoptosis are different in the NQO1 expressing and null cell lines. This indicates a different mechanism of activations and/ or activity for these agents in the presence of active NQO1 protein. We show that Es5 has a higher partition coefficient than RH1, which may enable Es5 to enter the brain. Following cleavage of the ester group Es5 produces a Quinone whose cytoxicity profile is comparable to RH1.
|